deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT01552707

Safety Study of Mesenchymal Stem Cells and Spinal Fusion

Ex Vivo Expanded Autologous Bone Marrow Mesenchymal Stem Cells Fixed in Allogenic Human Bone Tissue for Spinal Fusion in Spine Degenerative Disease

Sponsor: Banc de Sang i Teixits

Conditions Degenerative Discopathy Involving L4-L5 Lumbar Spondylolisthesis Involving L4-L5, and/or
Interventions Standard treatment XCEL-MT-OSTEO-ALPHA
Updated 10 times since 2017 Last updated: Jan 15, 2020 Started: Jul 19, 2012 Primary completion: May 3, 2018 Completion: Oct 21, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Degenerative Discopathy Involving L4-L5 and Lumbar Spondylolisthesis Involving L4-L5, and/or and is currently completed. Banc de Sang i Teixits leads this study, which shows 10 recorded versions since 2012 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Apr 2017 · 59 days · monthly snapshotRecruiting~Apr 2017 – ~Jun 2018 · 14 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshotActive Not Recruiting~Aug 2018 – ~Aug 2019 · 12 months · monthly snapshotActive Not Recruiting~Aug 2019 – ~Feb 2020 · 6 months · monthly snapshotActive Not Recruiting~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Feb 2020 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

    Status: Active Not Recruiting → Completed

  5. Aug 2019 — Feb 2020 [monthly]

    Active Not Recruiting PHASE1_PHASE2

▶ Show 5 earlier versions

  1. Aug 2018 — Aug 2019 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  2. Jun 2018 — Aug 2018 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  3. Apr 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE1_PHASE2

    Status: Recruiting → Active Not Recruiting

  4. Feb 2017 — Apr 2017 [monthly]

    Recruiting PHASE1_PHASE2

  5. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE1_PHASE2

    First recorded

Jul 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Banc de Sang i Teixits
  • Ministerio de Ciencia e Innovación, Spain
  • Ministerio de Sanidad, Servicios Sociales e Igualdad
  • TFS Trial Form Support
Data source: Banc de Sang i Teixits

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations